As expected, integrins interacting with ECM components are expressed in a cell‐type‐selective fashion, such as ITGA4, ITGAL and ITGB7 by immune cells, while tumour and stromal cells strongly expressed ITGA3, ITGAV and ITGB1/4/5/6/8. Here, ITGAL is linked to neoplasm.